Background/Aims: Native speakers often have a difficult time understanding non-native speech, and this challenge is frequently attributed to a more variable signal. While theories and models of general speech perception are grounded in issues of variability, they rarely consider non-native speech. Here, we ask how a specific type of variability (speaking rate) impacts two measures of perception for both native and non-native speech. Methods: In the present study, one group of listeners transcribed speech, providing a measure of intelligibility. A second group of listeners rated how fluent the speaker was, providing a measure of fluency. Results: The results show that variability in speaking rate correlates with a non-native speaker’s intelligibility. However, perceived fluency measures are not predicted by this variability measure. Conclusions: These results, taken with studies of the range of variability in non-native speech, suggest that variability in non-native speech is not a monolithic construct. Current theories and models of perception can be enhanced by examining non-native speech and how variability in that speech impacts perception.

This content is only available via PDF.
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.